Correction to ‘Resveratrol-loaded PLGA nanoparticles: enhanced stability, solubility and bioactivity of resveratrol for non-alcoholic fatty liver disease therapy’

Detalles Bibliográficos
Autores principales: Wan, S., Zhang, L., Quan, Y., Wei, K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society 2019
Materias:
Corrections
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366170/
https://www.ncbi.nlm.nih.gov/pubmed/30800409
http://dx.doi.org/10.1098/rsos.182173
_version_ 1783393568498384896
author Wan, S.
Zhang, L.
Quan, Y.
Wei, K.
author_facet Wan, S.
Zhang, L.
Quan, Y.
Wei, K.
author_sort Wan, S.
collection PubMed
description
format Online
Article
Text
id pubmed-6366170
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher The Royal Society
record_format MEDLINE/PubMed
spelling pubmed-63661702019-02-22 Correction to ‘Resveratrol-loaded PLGA nanoparticles: enhanced stability, solubility and bioactivity of resveratrol for non-alcoholic fatty liver disease therapy’ Wan, S. Zhang, L. Quan, Y. Wei, K. R Soc Open Sci Corrections The Royal Society 2019-01-16 /pmc/articles/PMC6366170/ /pubmed/30800409 http://dx.doi.org/10.1098/rsos.182173 Text en © 2019 The Authors. http://creativecommons.org/licenses/by/4.0/ Published by the Royal Society under the terms of the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/, which permits unrestricted use, provided the original author and source are credited.
spellingShingle Corrections
Wan, S.
Zhang, L.
Quan, Y.
Wei, K.
Correction to ‘Resveratrol-loaded PLGA nanoparticles: enhanced stability, solubility and bioactivity of resveratrol for non-alcoholic fatty liver disease therapy’
title Correction to ‘Resveratrol-loaded PLGA nanoparticles: enhanced stability, solubility and bioactivity of resveratrol for non-alcoholic fatty liver disease therapy’
title_full Correction to ‘Resveratrol-loaded PLGA nanoparticles: enhanced stability, solubility and bioactivity of resveratrol for non-alcoholic fatty liver disease therapy’
title_fullStr Correction to ‘Resveratrol-loaded PLGA nanoparticles: enhanced stability, solubility and bioactivity of resveratrol for non-alcoholic fatty liver disease therapy’
title_full_unstemmed Correction to ‘Resveratrol-loaded PLGA nanoparticles: enhanced stability, solubility and bioactivity of resveratrol for non-alcoholic fatty liver disease therapy’
title_short Correction to ‘Resveratrol-loaded PLGA nanoparticles: enhanced stability, solubility and bioactivity of resveratrol for non-alcoholic fatty liver disease therapy’
title_sort correction to ‘resveratrol-loaded plga nanoparticles: enhanced stability, solubility and bioactivity of resveratrol for non-alcoholic fatty liver disease therapy’
topic Corrections
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366170/
https://www.ncbi.nlm.nih.gov/pubmed/30800409
http://dx.doi.org/10.1098/rsos.182173
work_keys_str_mv AT wans correctiontoresveratrolloadedplgananoparticlesenhancedstabilitysolubilityandbioactivityofresveratrolfornonalcoholicfattyliverdiseasetherapy
AT zhangl correctiontoresveratrolloadedplgananoparticlesenhancedstabilitysolubilityandbioactivityofresveratrolfornonalcoholicfattyliverdiseasetherapy
AT quany correctiontoresveratrolloadedplgananoparticlesenhancedstabilitysolubilityandbioactivityofresveratrolfornonalcoholicfattyliverdiseasetherapy
AT weik correctiontoresveratrolloadedplgananoparticlesenhancedstabilitysolubilityandbioactivityofresveratrolfornonalcoholicfattyliverdiseasetherapy

Ejemplares similares